ISDS Case Map
medicines
Recently leaked documents show that India’s policies on software and pharmaceutical patents are firmly on the RCEP agenda.
NZ is heading towards a two-tier health system, and it could get a whole lot worse, writes George Laking.
As the eighth round of negotiations on the Regional Comprehensive Economic Partnership (RCEP) trade agreement take place in Kyoto, Japan this week, farmer’s groups, trade unions, civil society and patient groups are urging the Indian Government to halt the negotiations, make the negotiating texts public and hold consultations with all the relevant stakeholders, in light of the potential negative impact this agreement could have on access to medicines, livelihood of farmers, quality public services and overall social and economic development of the country.
On Wednesday 10 June 2015, WikiLeaks published the Healthcare Annex to the secret draft "Transparency" Chapter of the Trans-Pacific Partnership Agreement (TPP), along with each country's negotiating position.
Two-page summary of the main provisions in the Trans-Pacific Partnership Agreement (TPP) that will lead to higher prices for drugs and other medical technologies.
Trade negotiators for the Trans-Pacific Partnership agreement in Guam are now focusing on intellectual property issues, which appear likely to be the last hurdle to concluding the talks.
On Monday, a coalition of Peruvian civil society organizations issued a strong warning as negotiations for the Trans Pacific Partnership treaty (TPP) come to an end.
A new report from the prominent AIDS research group amfAR says that the Trans-Pacific Partnership would hamper the global fight against AIDS (and other diseases) in a way that would ultimately cost lives.
A text that Peru and 11 other countries (including the US) are negotiating in secret, seeks to expand drug patents for more than 20 years thus generating millions of overheads for our health system and making it even more difficult to obtain biological medicines against cancer.
Australia's primary negotiator on medicines for the US-Australia FTA, Dr Ruth Lopert, warns that the TPP could force the Australian Government to spend hundreds of millions of dollars to subsidise medicines.
